Follow
Chapman KR
Chapman KR
Verified email at utoronto.ca - Homepage
Title
Cited by
Cited by
Year
Epidemiology and costs of chronic obstructive pulmonary disease
KR Chapman, DM Mannino, JB Soriano, PA Vermeire, AS Buist, MJ Thun, ...
European Respiratory Journal 27 (1), 188-207, 2006
11812006
Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD
JA Wedzicha, D Banerji, KR Chapman, J Vestbo, N Roche, RT Ayers, ...
New England Journal of Medicine 374 (23), 2222-2234, 2016
10562016
Tiotropium in combination with placebo, salmeterol, or fluticasone–salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial
SD Aaron, KL Vandemheen, D Fergusson, F Maltais, J Bourbeau, ...
Annals of internal medicine 146 (8), 545-555, 2007
9882007
Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide.
PE Silkoff, PA McClean, AS Slutsky, HG Furlott, E Hoffstein, S Wakita, ...
American journal of respiratory and critical care medicine 155 (1), 260-267, 1997
5581997
Gender bias in the diagnosis of COPD
KR Chapman, DP Tashkin, DJ Pye
Chest 119 (6), 1691-1695, 2001
5452001
Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ...
The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021
5072021
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
KR Chapman, JGW Burdon, E Piitulainen, RA Sandhaus, N Seersholm, ...
The Lancet 386 (9991), 360-368, 2015
5042015
Suboptimal asthma control: prevalence, detection and consequences in general practice
KR Chapman, LP Boulet, RM Rea, E Franssen
European Respiratory Journal 31 (2), 320-325, 2008
4902008
Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response.
LP Boulet, KR Chapman, J Cote, S Kalra, R Bhagat, VA Swystun, ...
American journal of respiratory and critical care medicine 155 (6), 1835-1840, 1997
4821997
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
NA Hanania, P Korenblat, KR Chapman, ED Bateman, P Kopecky, ...
The Lancet Respiratory Medicine 4 (10), 781-796, 2016
4722016
Minimal clinically important differences in pharmacological trials
PW Jones, KM Beeh, KR Chapman, M Decramer, DA Mahler, ...
American journal of respiratory and critical care medicine 189 (3), 250-255, 2014
4712014
Medical personnel's knowledge of and ability to use inhaling devices: metered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers
NA Hanania, R Wittman, S Kesten, KR Chapman
Chest 105 (1), 111-116, 1994
3791994
Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room
AS Rebuck, KR Chapman, R Abboud, PD Pare, H Kreisman, N Wolkove, ...
The American journal of medicine 82 (1), 59-64, 1987
3651987
Adverse effects of inhaled corticosteroids
NA Hanania, KR Chapman, S Kesten
The American journal of medicine 98 (2), 196-208, 1995
3471995
Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study
ML Decramer, KR Chapman, R Dahl, P Frith, G Devouassoux, C Fritscher, ...
The lancet Respiratory medicine 1 (7), 524-533, 2013
3282013
Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ...
The Lancet Respiratory Medicine 10 (8), 761-775, 2022
3162022
A cohort study of traffic-related air pollution and mortality in Toronto, Ontario, Canada
M Jerrett, MM Finkelstein, JR Brook, MA Arain, P Kanaroglou, DM Stieb, ...
Environmental health perspectives 117 (5), 772-777, 2009
2912009
Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study
JM FitzGerald, LP Boulet, RA McIvor, S Zimmerman, KR Chapman
Canadian respiratory journal 13 (5), 253-259, 2006
2872006
Adult asthma consensus guidelines update 2003
C Lemière, T Bai, M Balter, C Bayliff, A Becker, LP Boulet, D Bowie, ...
Canadian respiratory journal 11, 9A-18A, 2004
2652004
Exhaled nitric oxide as a noninvasive assessment of chronic cough
JM Chatkin, K Ansarin, PE Silkoff, P McCLEAN, C Gutierrez, NOE Zamel, ...
American journal of respiratory and critical care medicine 159 (6), 1810-1813, 1999
2601999
The system can't perform the operation now. Try again later.
Articles 1–20